Trials / Unknown
UnknownNCT04725760
Evaluation of the Efficacy of the BrainPort Vision Pro on the Performance of Daily Activities in the Profoundly Blind French Population
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 125 (estimated)
- Sponsor
- Wicab · Industry
- Sex
- All
- Age
- 8 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to evaluate the effectiveness and safety of the BrainPort® Vision Pro, an electronic oral assistive device, in the performance of daily tasks by French persons who have residual vision limited to light perception or less in both eyes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BrainPort Vision Pro | Ten hours of training over 3 to 5 days, followed by autonomous use of the device. It will be recommended that the subject use the BrainPort® Vision Pro device for at least 5 hours per month for a period of 12 months. |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2022-09-30
- Completion
- 2022-09-30
- First posted
- 2021-01-27
- Last updated
- 2021-11-10
Locations
7 sites across 1 country: France
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04725760. Inclusion in this directory is not an endorsement.